F-group (family)
101.1.10.7 Cyclin_C
Ligands and drugs
696
Member domains
59
with ligand contacts (≤ 4 Å)
8.5% of members
40
with DrugDomain annotations
5.7% of members
38
with a DrugBank compound
5.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 101.1.10.7 belongs to X-group 101 HTH, which binds 8.7 ligand superclasses per 20 proteins, broader than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03864 | SGM | Monothioglycerol | 21 |
| DB00945 | — | Acetylsalicylic acid | 1 |
| DB01169 | — | — | 1 |
| DB02091 | — | 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine | 1 |
| DB02407 | — | 6-O-Cyclohexylmethyl Guanine | 1 |
| DB02833 | — | [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine | 1 |
| DB02915 | — | 4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine | 1 |
| DB06844 | — | 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE | 1 |
| DB06944 | — | N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide | 1 |
| DB06948 | — | 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE | 1 |
| DB07126 | — | O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE | 1 |
| DB07137 | — | (2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide | 1 |
| DB07164 | — | N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine | 1 |
| DB07203 | — | 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE | 1 |
| DB07471 | — | 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE | 1 |
| DB07533 | — | 4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]-2-Furyl}-N-Methylbenzenesulfonamide | 1 |
| DB07534 | — | 4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]furan-2-Yl}benzenesulfonamide | 1 |
| DB07538 | — | 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | 1 |
| DB07539 | — | 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID | 1 |
| DB07562 | — | N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SGM | MONOTHIOGLYCEROL | 21 |
| IJF | (4-bromanylpyridin-2-yl)methanol | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| UU1 | 2-(4-bromo-1H-pyrazol-1-yl)ethan-1-ol | 2 |
| 1P8 | 6-bromo-1,3-dihydro-2H-indol-2-one | 1 |
| A1AC4 | (8R)-N-[(2S,3R)-3-(cyclohexylmethoxy)-1-(morpholin-4-yl)-1-oxobutan-2-yl]-2-[(1S)-2,2-dimethylcyclopropane-1-carbonyl]-6-(1,3-thiazole-5-carbonyl)-2,6-diazaspiro[3.4]octane-8-carboxamide | 1 |
| A1AC5 | (8R)-6-(1-benzyl-1H-pyrazole-4-carbonyl)-N-[(2S,3R)-3-(2-cyclohexylethoxy)-1-(methylamino)-1-oxobutan-2-yl]-2-[(1S)-2,2-dimethylcyclopropane-1-carbonyl]-2,6-diazaspiro[3.4]octane-8-carboxamide | 1 |
| HH8 | 4-bromanyl-1,8-naphthyridine | 1 |
| HHT | 2-(4-bromanyl-2-methoxy-phenyl)ethanoic acid | 1 |
| NAmetal | SODIUM ION | 1 |
| UUG | (4-bromo-2-methoxyphenyl)methanol | 1 |